Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Chelating Agents (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Chelating Agents (history) < Chelating Agents (therapeutic use) < Chelation Therapy  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000072 (1999) J M Walshe [Royaume-Uni]Penicillamine: the treatment of first choice for patients with Wilson's disease.
000073 (1999) G J Brewer [États-Unis]Penicillamine should not be used as initial therapy in Wilson's disease.
000074 (1999) P A LewittPenicillamine as a controversial treatment for Wilson's disease.
000B13 (2003) John M. Walshe [Royaume-Uni]The story of penicillamine: a difficult birth.
001210 (2005) Nathan E. Crone [États-Unis] ; H A Jinnah ; Stephen G. ReichWilson's disease presenting with an unusual cough.
001931 (2007) Melis Sohtaoglu ; Hayal Ergin ; Sibel Ozekmekçi ; Selim Gökdemir ; Abdullah Sonsuz ; Ceyhun AriciPatient with late-onset Wilson's disease: deterioration with penicillamine.
001E70 (2008) Barbara Leinweber [Allemagne] ; J Carsten Möller ; Andre Scherag ; Ulrike Reuner ; Peter Günther ; Christoph J G. Lang ; Hartmut H J. Schmidt ; Christoph Schrader ; Oliver Bandmann ; Anna Czlonkowska ; Wolfgang H. Oertel ; Harald HefterEvaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
002053 (2008) Hee K. Park ; Seung M. Kim ; Choong G. Choi ; Myoung C. Lee ; Sun J. ChungEffect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration.
003776 (2012) Maria Stamelou [Royaume-Uni] ; Karin Tuschl [Royaume-Uni] ; W K Chong [Royaume-Uni] ; Andrew K. Burroughs [Royaume-Uni] ; Philippa B. Mills [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Peter T. Clayton [Royaume-Uni]Dystonia with Brain Manganese Accumulation Resulting From SLC30A10 Mutations: A New Treatable Disorder
004D60 (1997) A A Yorio [Argentine] ; J C Mesri ; M A Pagano ; G. LeraStereotypies in Wilson's disease.
004E86 (1998) D J Cordato [Australie] ; M J Fulham ; C. YiannikasPretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Chelating Agents (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Chelating Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Chelating Agents (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024